Subscribe

Ashish Saxena, MD, PhD

Articles by Ashish Saxena, MD, PhD

Dr. Saxena on the Importance of Initial Treatment Selection in ALK+ NSCLC

ByAshish Saxena, MD, PhD

January 24th 2020

Ashish Saxena, MD, PhD, discusses the importance of initial therapy selection in ALK-positive non–small cell lung cancer.

Latest Updated Articles

Dr. Saxena on the Importance of Initial Treatment Selection in ALK+ NSCLC
Published: January 24th 2020 | Updated:

Trending on CGTlive®

Around the Helix: Cell and Gene Therapy Company Updates – November 5, 2025

What Were the Most Significant Inflection Points or Breakthroughs in Cell and Gene Therapy?

Evaluating CAR-T KYV-101 for Generalized Myasthenia Gravis

Guess the Therapy Answer November 5, 2025

© 2025 MJH Life Sciences^®

All rights reserved.